Scott E. Lazerwith
Impact in
- Pharmacology top 2%
- Cannabis and Cannabinoid Research
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Biochemical and Molecular Research 2
-
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Kay Ahn (3 shared papers)Douglas S. Johnson (3 shared papers)Marya Liimatta (3 shared papers)Cory M. Stiff (3 shared papers)Sarah E. Smith (3 shared papers)David Beidler (3 shared papers)Benjamin F. Cravatt (3 shared papers)E. J. Corey (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Journal of the American Chemical Society (3 papers)Journal of Hepatology (2 papers)Bioorganic & Medicinal Chemistry Letters (1 paper)Xenobiotica (1 paper)
- Partner nations
- United StatesHong KongCanada
In The Last Decade
Scott E. Lazerwith
15 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Pharmacology 471
- Virology 128
- Toxicology 79
- Infectious Diseases 233
- Organic Chemistry 269
Countries citing papers authored by Scott E. Lazerwith
This map shows the geographic impact of Scott E. Lazerwith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Lazerwith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Lazerwith more than expected).
Fields of papers citing papers by Scott E. Lazerwith
This network shows the impact of papers produced by Scott E. Lazerwith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Lazerwith. The network helps show where Scott E. Lazerwith may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott E. Lazerwith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 384 | |
| 2 | 2016 | 228 | |
| 3 | 2010 | 160 | |
| 4 | 2005 | 83 | |
| 5 | 2009 | 60 | |
| 6 | 1998 | 58 | |
| 7 | 1997 | 51 | |
| 8 | 2000 | 47 | |
| 9 | 2021 | 26 | |
| 10 | 2013 | 20 | |
| 11 | 2019 | 13 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 3 | |
| 14 | 2017 | 1 | |
| 15 | 2017 | 1 |
About Scott E. Lazerwith
Scott E. Lazerwith is a scholar working on Molecular Biology, Epidemiology, Infectious Diseases, Virology and Hepatology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (5 papers), Liver Disease Diagnosis and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (4 papers), Hepatitis C virus research (4 papers), Cannabis and Cannabinoid Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Pharmacology (471 citations), Virology (128 citations), Toxicology (79 citations), Infectious Diseases (233 citations) and Organic Chemistry (269 citations). Scott E. Lazerwith has collaborated with scholars based in United States, Hong Kong and Canada. Frequent co-authors include Kay Ahn, Douglas S. Johnson, Marya Liimatta, Cory M. Stiff, Sarah E. Smith, David Beidler, Benjamin F. Cravatt, E. J. Corey, Nalini Sadagopan and E.J. Corey. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of the American Chemical Society, Journal of Hepatology, Bioorganic & Medicinal Chemistry Letters and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.